Financial Gravity Asset Management, Inc. Glaukos Corp Transaction History

Financial Gravity Asset Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 28, 2020	SELL	$54.18 - $65.64 $812 - $984	-15 Closed	0 $0
Q3 2019 Oct 15, 2019	SELL	$58.58 - $83.91 $234 - $335	-4 Reduced 21.05%	15 $1,000
Q2 2019 Jul 26, 2019	SELL	$63.59 - $78.71 $572 - $708	-9 Reduced 32.14%	19 $1,000
Q1 2019 Apr 19, 2019	BUY	$50.75 - $80.54 $1,421 - $2,255	28 New	28 $2,000

341

46.8M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.18B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.